MedPath

Eywa Pharma Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

FDA:15

Drug Approvals

Ursodiol

Approval Date
Dec 8, 2023
FDA

Acetazolamide

Approval Date
Dec 8, 2023
FDA

Methylphenidate Hydrochloride

Approval Date
Nov 8, 2023
FDA

Hydrocodone Bitartrate and Acetaminophen

Approval Date
Oct 17, 2022
FDA

Labetalol Hydrochloride

Approval Date
Jul 7, 2022
FDA

Baclofen

Approval Date
Mar 11, 2022
FDA

Ondansetron

Approval Date
Jan 25, 2022
FDA

Quinidine gluconate

Approval Date
Dec 29, 2021
FDA

Potassium-cit

Approval Date
Dec 27, 2021
FDA

Oxycodone Hydrochloride

Approval Date
Oct 11, 2021
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

Biocon Inaugurates First US Manufacturing Facility in New Jersey with $30 Million Investment

Biocon Limited has opened its first FDA-approved manufacturing facility in Cranbury, New Jersey, through its subsidiary Biocon Generics Inc, marking a significant milestone in the company's global expansion strategy.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.